Start up pharmaceutical companies are not priced based on revenues. They are supposed to be priced based on future trials and long term potential of future drugs. Of course this is the OTCBB where there is no rhyme or reason to the way stocks are priced so its anything goes.
News 
Market Data 
Discover 
AI
